Alan R. Crossman
Affiliations: | The University of Manchester, Manchester, England, United Kingdom |
Area:
neurodegenerative disordersGoogle:
"Alan Crossman"Mean distance: 16.38 (cluster 6)
Children
Sign in to add trainee| Tipu Zahed Aziz | grad student | Oxford | |
| Mark D. Bevan | grad student | ||
| Jonathan M. Brotchie | grad student | The University of Manchester | |
| Erwan Bezard | post-doc | 1999-2000 | The University of Manchester |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fridjonsdottir E, Shariatgorji R, Nilsson A, et al. (2021) Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA-induced dyskinesia. Science Advances. 7 |
| Bezard E, Li Q, Hulme H, et al. (2020) µ opioid receptor agonism for L-DOPA-induced dyskinesia in Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience |
| Cenci MA, Crossman AR. (2018) Animal models of l-dopa-induced dyskinesia in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society |
| Bastide MF, Meissner WG, Picconi B, et al. (2015) Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology |
| Shariatgorji M, Nilsson A, Goodwin RJ, et al. (2014) Direct targeted quantitative molecular imaging of neurotransmitters in brain tissue sections. Neuron. 84: 697-707 |
| Ko WK, Martin-Negrier ML, Bezard E, et al. (2014) RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease. Neurobiology of Disease. 70: 138-48 |
| Kobylecki C, Burn DJ, Kass-Iliyya L, et al. (2014) Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease. Parkinsonism & Related Disorders. 20: 452-5 |
| Bourdenx M, Nilsson A, Wadensten H, et al. (2014) Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesia. Neurobiology of Disease. 62: 307-12 |
| Obeso JA, Guridi J, Nambu A, et al. (2013) Motor manifestations and basal ganglia output activity: the paradox continues. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 416-8 |
| Kobylecki C, Crossman AR, Ravenscroft P. (2013) Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia. Experimental Neurology. 247: 476-84 |